APPENDIX 1
Public submissions received by the committee
Submissions
received:
1 Confidential
Submission
2 Thornley,
Dr Stephen
3 Confidential
Submission
4 Confidential
Submission
5 Kandiah,
Dr David A
6 Eisman,
Professor John
7 Littlejohn,
Professor Geoff
8 Glendenning,
Professor Paul
9 Australian
and NZ Bone and Mineral Society
10 Oakley,
Dr Stephen
11 Major,
Dr Gabor
12 Australian
Medical Association (AMA)
13 Inderjeeth,
Dr Charles A
14 Chronic
Illness Alliance
15 Joint
Epilepsy Council of Australia and Epilepsy Australia
16 Generic
Medicines Industry Association Pty Ltd
17 Pharmaceutical
Society of Australia
18 The
Pharmacy Guild of Australia
19 Janssen-Cilag
Australia
20 Consumers
Health Forum of Australia
21 Osteoporosis
Australia
22 Paroxysmal
Nocturnal Haemoglobinuria (PNH) Support Association of Australia
23 Sanofi-Aventis
Australia Pty Limited
24 Arthritis
Australia
25 Mental
Health Council of Australia
26 Carers
Australia
27 Department
of Health and Ageing
28 MS
Australia
29 Medicines
Australia
30 Hill,
Minister John
31 AstraZeneca
Pty Ltd
32 Faunce,
Dr Thomas
33 Pfizer
Australia
34 Australian
NPC Disease Foundation Inc (VIC)
35 Abbott
Australasia Pty Ltd
Additional information:
|
Arthritis Australia
- Response to questions taken on notice at public hearing
07.05.10, received 20.05.10
|
|
AstraZeneca Pty Ltd
- Response to questions taken on notice at public hearing
07.05.10 and Supplementary submission, received 31.05.10
|
|
Australian and NZ Bone and Mineral Society
-
Additional information referred to and provided at public
hearing 07.05.10
-
Response to questions taken on notice at hearing 07.05.10,
received 22.05.10
|
|
Chronic Illness
Alliance
- Response to questions taken on notice at public hearing
07.05.10
|
|
Consumers Health Forum of Australia
- Response to questions taken on notice at public hearing
07.05.10, received 19.05.10
|
|
Department of Health and Ageing
- Response to questions taken on notice at public hearing
07.05.10, received 15.06.10
- Response to Committee correspondence seeking views on the
Memorandum of Understanding signed between the Australian Government and
Medicines Australia, received 16.06.10
|
|
Generic Medicines Industry Association Pty Ltd
- Correction to the record from public hearing 07.05.10, dated
17.05.10
- Additional information arising from hearing, dated 18.05.10
|
|
Janssen-Cilag Australia
- Supplementary submission and response
to questions taken on notice at public hearing 07.05.10, received 31.05.10
|
|
Medicines Australia
- Supplementary submission and response to questions taken on
notice at public hearing 07.05.10, received 31.05.10
- Response to Committee correspondence seeking views on the
Memorandum of Understanding signed between the Australian Government and
Medicines Australia, received 10.06.10
|
|
Mental Health Council of Australia
- Response to questions taken on notice at public hearing
07.05.10, received 25.05.10
|
|
Pfizer Australia
- Supplementary submission and response
to questions taken on notice at public hearing 07.05.10, received 01.06.10
|
|
Pharmaceutical Benefits Advisory Council
- Response to questions taken on notice at public hearing
07.05.10, received 16.06.10
|
|
The Pharmacy Guild of Australia
- Supplementary submission including response to questions taken
on notice at public hearing 07.05.10, received 14.05.10
- Response to Committee correspondence seeking views on the
Memorandum of Understanding signed between the Australian Government and
Medicines Australia, received 09.06.10
|
|
Sanofi-Aventis Australia Pty Limited
- Response to questions taken on notice at public hearing
07.05.10, received 31.05.10
|
Navigation: Previous Page | Contents | Next Page